Lucid Diagnostics logo

Lucid Diagnostics Share Price (NASDAQ: LUCD)

Market is closed - opens 7 PM IST, 04 Aug 2025

$1

0.02

(2.04%)

Last updated on 02 Aug 2025, 01:29 AM IST

Check the interactive Lucid Diagnostics Stock chart to analyse performance

Lucid Diagnostics stock performance

as on 02 Aug 2025, 01:29 AM IST

  • Today's Low: $0.95
    Today's High: $1.00

    Day's Volatility :5.01%

  • 52 Weeks Low: $0.72
    52 Weeks High: $1.80

    52 Weeks Volatility :59.99%

Lucid Diagnostics Stock Returns

PeriodLucid Diagnostics Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-21.05%
-5.9%
0.0%
6 Months
8.45%
-11.2%
0.0%
1 Year
31.32%
-13.5%
0.0%
3 Years
-67.1%
-0.4%
-6.0%

Lucid Diagnostics Inc. Key Stats

Check Lucid Diagnostics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.98
Open
$0.98
Today's High
$1.0
Today's Low
$0.9499
Market Capitalization
$105.9M
Today's Volume
$1.1M
52 Week High
$1.8
52 Week Low
$0.7201
Revenue TTM
$4.2M
EBITDA
$-46.9M
Earnings Per Share (EPS)
$-1.17
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1897.35%

Stock Returns calculator for Lucid Diagnostics Stock including INR - Dollar returns

The Lucid Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lucid Diagnostics investment value today

Current value as on today

₹1,37,747

Returns

₹37,747

(+37.75%)

Returns from Lucid Diagnostics Stock

₹33,333 (+33.33%)

Dollar Returns*

₹4,413 (+4.41%)

Indian investors sentiment towards Lucid Diagnostics Stock

76%

Period: Jul 2, 2025 to Aug 1, 2025. Change in 30 Days versus previous period

Search interest for Lucid Diagnostics Stock from India on INDmoney has increased by 76% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lucid Diagnostics Inc.

  • Name

    Holdings %

  • Masters Capital Management LLC

    2.52%

  • Alyeska Investment Group, L.P.

    1.74%

  • Vanguard Group Inc

    0.82%

  • Renaissance Technologies Corp

    0.42%

  • Luminus Management, LLC

    0.42%

  • Ghisallo Capital Management LLC

    0.39%

Analyst Recommendation on Lucid Diagnostics Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Lucid Diagnostics(by analysts ranked 0 to 5 stars)

Lucid Diagnostics Share Price Target

What analysts predicted

Upside of 279.17%

Target:

$3.79

Current:

$1.00

Lucid Diagnostics share price target is $3.79, a slight Upside of 279.17% compared to current price of $1.00 as per analysts' prediction.

Lucid Diagnostics Stock Insights

  • Price Movement

    In the last 3 months, LUCD stock has moved down by -23.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.19M → 828.0K (in $), with an average decrease of 30.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -11.54M → -26.90M (in $), with an average decrease of 133.2% per quarter
  • LUCD vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 40.9% return, outperforming this stock by 9.6%
  • LUCD vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 153.1% return, outperforming this stock by 220.0%
  • Price to Sales

    ForLUCD every $1 of sales, investors are willing to pay $13.5, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Lucid Diagnostics Technicals Summary

Sell

Neutral

Buy

Lucid Diagnostics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Lucid Diagnostics Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lucid Diagnostics Inc. logo
-4.18%
8.45%
31.32%
-67.1%
-91.61%
Medtronic Plc logo
2.1%
-0.31%
10.72%
-3.75%
-7.27%
Edwards Lifesciences Corp. logo
3.27%
11.1%
30.36%
-23.34%
1.64%
Boston Scientific Corp. logo
0.6%
1.82%
40.87%
152.15%
176.17%
Stryker Corporation logo
-0.27%
0.79%
18.9%
82.6%
105.76%
Abbott Laboratories logo
-6.11%
-1.73%
13.4%
15.16%
25.38%

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.
Organization
Lucid Diagnostics
Employees
72
CEO
Dr. Lishan Aklog M.D.
Industry
Healthcare

Key Management of Lucid Diagnostics Inc.

NameTitle
Dr. Lishan Aklog M.D.
Chairman & CEO
Mr. Shaun M. O'Neill M.B.A.
President & COO
Mr. Michael Adam Gordon
General Counsel & Secretary
Dr. Sanford D. Markowitz M.D., Ph.D.
Co-Founder & Strategic Advisor
Dr. Joseph Willis M.D.
Co-founder & Strategic Advisor
Dr. Amitabh Chak M.D.
Co-Founder & Strategic Advisor
Helen Moinova Ph.D.
Co-Founder & Strategic Advisor
Dr. Brian J. deGuzman M.D.
Chief Technology & Compliance Officer
Dr. Suman M. Verma M.D., Ph.D.
Chief Scientific Officer
Mr. Matthew Riley
Director of Investor Relations

Important FAQs about investing in LUCD Stock from India :

How to invest in Lucid Diagnostics Stock (LUCD) from India?

It is very easy for Indian residents to invest directly in Lucid Diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lucid Diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lucid Diagnostics or LUCD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lucid Diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lucid Diagnostics shares which would translate to 0.874 fractional shares of Lucid Diagnostics as of today. Learn more about fractional investing.

Can Indians buy Lucid Diagnostics shares?

Yes, Indians can invest in the Lucid Diagnostics (LUCD) from India.

With INDmoney, you can buy Lucid Diagnostics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lucid Diagnostics at zero transaction cost.

How can I buy Lucid Diagnostics shares from India?

It is very easy to buy Lucid Diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lucid Diagnostics (LUCD) be purchased?

Yes, you can buy fractional shares of Lucid Diagnostics with INDmoney app.

What are the documents required to start investing in Lucid Diagnostics stocks?

To start investing in Lucid Diagnostics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Lucid Diagnostics share price today?

Lucid Diagnostics share price today stands at $1.00, Open: $0.98 ; Previous Close: $0.98 ; High: $1.00 ; Low: $0.95 ; 52 Week High: $1.80 ; 52 Week Low: $0.72.

The stock opens at $0.98, after a closing price of $0.98. The stock reached a daily high of $1.00 and a low of $0.95, with a 52-week high of $1.80 and a 52-week low of $0.72.

What are today’s High and Low prices of Lucid Diagnostics Stock (LUCD)?

Today’s highest price of Lucid Diagnostics (LUCD) is $1.00.

Today’s lowest price of Lucid Diagnostics (LUCD) is $0.95.

What is the 52 Week High and Low Range of Lucid Diagnostics Stock (LUCD)?

  • 52 Week High

    $1.80

  • 52 Week Low

    $0.72

What are the historical returns of Lucid Diagnostics (LUCD)?

  • 1 Month Returns

    -4.18%

  • 3 Months Returns

    8.45%

  • 1 Year Returns

    31.32%

  • 5 Years Returns

    -91.61%

What is today's market capitalisation of Lucid Diagnostics?

Today's market capitalisation of Lucid Diagnostics LUCD is 109.3M

Who is the Chief Executive Officer (CEO) of Lucid Diagnostics ?

Dr. Lishan Aklog M.D. is the current Chief Executive Officer (CEO) of Lucid Diagnostics.